NCT00438919View on ClinicalTrials.gov

A Multi-center Post-Market Surveillance Registry

PHASE4CompletedINTERVENTIONAL
Enrollment

15,000

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

December 31, 2009

Conditions
Coronary Artery Disease
Interventions
DEVICE

drug-eluting stent

CYPHER SELECT™ Sirolimus-eluting Coronary Stent

Trial Locations (1)

1217

Clinique La Tour, Meyrin

Sponsors

Lead Sponsor

Cordis Corporation
All Listed Sponsors
lead

Cordis Corporation

INDUSTRY

NCT00438919 - A Multi-center Post-Market Surveillance Registry | Biotech Hunter | Biotech Hunter